Abstract:To the Editor : Otosclerosis is a hearing disorder which is associated with disordered bone remodelling in the otic capsule. The bone remodelling can lead to conductive, mixed or sensorineural hearing loss as a result of stapes footplate fixation or cochlear involvement, respectively. Although its etiology remains unknown, otosclerosis can be considered a complex disease with rare monogenic forms. Linkage analysis in large families segregating autosomal dominant otosclerosis has led to the identification of seven loci (OTSC1–5, 7–8 ). None of the corresponding genes has been identified, but in the OTSC2 region indications have been found that suggest TCRB as the causative gene (1). In this study, a new large Dutch otosclerosis family with autosomal dominant inheritance was investigated (Fig. 1). The materials and methods used are described in the Supporting information (Appendix S1 and Table S1). The known otosclerosis loci and the NOG gene (noggin) were excluded for linkage in this family by analysis of at least three informative microsatellite markers in each region. Linkage to the NOG gene was investigated because it is involved in syndromic cases of stapes fixation (2). Subsequently, a genome wide screen was performed. Multipoint linkage analysis revealed only one region with a LOD score above 1, and 89% of the genome could be excluded (LOD <−2). This region is localized on chr1q41–44 and was confirmed by analysing 27 extra microsatellite markers. Multipoint linkage analysis showed a maximum LOD score of 3.3. Figure 1 shows the reconstructed haplotypes of a subset of the analysed markers in all family members. This locus, named OTSC10, has a candidate region of 26.1 Mb and contains 306 genes/gene predictions based on the latest draft of the human genome sequence (Build 37.1). Thirty-seven of these genes are reported to be expressed in the inner ear and 62 in bone tissue (3, 4). The complete OTSC10 region was screened for copy number variants (CNVs) on the basis of the SNP microarray, but we could not detect any aberration in the linked region in the patients (data not shown). In addition, two interesting genes in the region (transforming growth factor beta 2 (TGFB2 ) and angiotensinogen (AGT )) were selected for mutation analysis by DNA sequencing. These genes were selected because of their important role in bone remodelling and on the basis of previously found associations with otosclerosis (5–7). All exons and intron–exon boundaries were sequenced in two affected individuals, but no pathogenic variant could be identified in both genes. Reduced penetrance is common in otosclerosis and has been estimated to be around 40% on average (8), although this can vary greatly between families. The families linked to the earlier reported loci also illustrate a reduced and diverse penetrance (9–15). In addition, otosclerosis has a varying age of onset, which is usually between 16 and 50 years, but development at later ages is also possible (16). Both these facts suggest that the presence of other modifier factors, such as environment factors and/or modifier genes. Reduced penetrance and a varying age of onset is also present in this family (Fig. 1). The mean age of onset was 31 years, but this ranged between 16 and 51 years. Individuals III:5, III:13, III:15 and III:16 have a negative clinical diagnosis, but have inherited the disease haplotype or might carry the disease-causing mutation because they have inherited part of the disease haplotype. Their ages range from 52 to 57 years, so they might still develop the disease, but it is also possible that they will never express it as a result of the interference of additional genetic or environmental factors. In conclusion, we were able to identify a new locus for otosclerosis on chr1q41–44 (OTSC10 ). This new gene localization confirms the strong genetic heterogeneity of otosclerosis, as until now almost every new large family maps to a different locus. Currently, there is little knowledge on the pathological processes involved in otosclerosis. Identification of the first gene for otosclerosis will

Phenotype of the first otosclerosis family linked to OTSC10

A new locus for otosclerosis, OTSC10, maps to chromosome 1q41–44

Phenotype-genotype correlations in otosclerosis: clinical features of OTSC2

Audiological and Genetic Studies on Large Families with Non-Syndromic Deafness

A pathogenic deletion in Forkhead Box L1 (FOXL1) identifies the first otosclerosis (OTSC) gene

The natural history of OTOF-related auditory neuropathy spectrum disorders: a multicenter study

Clinical and genetic analysis of two Tunisian otosclerosis families

Monogenic nonsyndromic otosclerosis: audiological and linkage analysis in a large Greek pedigree

Involvement of T-cell receptor-beta alterations in the development of otosclerosis linked to OTSC2

Analysis of the Genetic Characteristics of a Chinese Family With Otosclerosis

The genetics of otosclerosis: pedigree studies and linkage analysis

The natural history, clinical outcomes, and genotype-phenotype relationship of otoferlin-related hearing loss: a systematic, quantitative literature review

Novel heterozygous mutations in the otogelin-like (OTOGL) gene in a child with bilateral mild nonsyndromic sensorineural hearing loss

Genetics of otosclerosis: finally catching up with other complex traits?

Targeted next generation sequencing reveals OTOF mutations in auditory neuropathy spectrum disorder

Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan

Hearing loss secondary to variants in the OTOF gene

Characterization of a stapes ankylosis family with a NOG mutation

Audiometric characterization of a family with digenic autosomal, dominant, progressive sensorineural hearing loss

An introduction of genetics in otosclerosis: a systematic review

Variable degrees of hearing impairment in a Dutch DFNX4 (DFN6) family